First new Alzheimer treatment in 20 years approved

First new Alzheimer treatment in 20 years approved External link

The first new treatment for Alzheimer's disease for nearly 20 years has been approved by regulators in the United States, paving the way for its use in the UK. Aducanumab targets the underlying cause of Alzheimer's, the most common form of dementia, rather than its symptoms.

Tagsalzheimer's disease
Content typeLINK